Post by GSK on X
GSK@GSK
X#News for #investors and #media: Today we are announcing that our potential first-in-class treatment for chronic hepatitis B has been accepted for regulatory review by the US FDA.
It has also received Breakthrough Therapy designation.
🔗 Learn more: t.co
22 likes0 repliesPosted Apr 28, 2026